Is it too early to nick-name True Nature’s Medtech incubator Mitesco the “Mighty Mitesco?” Of course it’s too early – but it appears that speculative micro-cap investors are sniffing around and trying to get positioned here before news, rather than after news. Perked up 70% yesterday, on 4 million shares.
May the force be with them!
This is not a trading idea, as we don’t traffic in trading ideas. As a practice, we look two to three years out with the majority of our ideas, particularly with clients, of which TNTY is on record of being. We see no need for real-time quotes!
So whether the stock is $0.01 or $0.10 is of little interest to us. We will be following the progress of their recently announced intentions to implement an incubator strategy – which takes a considerable amount of time to roll out, even though actual early implementation news could spur the shares significantly higher.
(Client, see research report for disclaimer and disclosure details or click here).